MedPath

Cranioplasty Cognitive Outcome Study

Not Applicable
Conditions
Cognitive Impairment
Brain Herniation
Interventions
Procedure: "Early" cranioplasty
Registration Number
NCT03791996
Lead Sponsor
Kwong Wah Hospital
Brief Summary

This will be a multicenter prospective randomized study of adult patients with an acquired skull defect as a result of craniectomy and considered suitable for cranioplasty, i.e. reconstruction of the skull defect, at all seven Hong Kong Hospital Authority neurosurgical units. Patients that underwent their primary craniectomy operation at any of the Hospital Authority neurosurgery centers from the 1st March 2019 and considered suitable for cranioplasty will be included in this study. Those who underwent their primary craniectomy before 1st March 2019 or at an institution other than the aforementioned neurosurgical units will be excluded. Data from clinical records, operation notes, medication-dispensing records, laboratory records and radiological reports will be collected.

30 adult patients with craniectomy will be recruited and randomized into two groups: "early" cranioplasty, i.e. performed within 3 months of craniectomy, and "late", i.e. cranioplasty performed more than 3 months after the operation. The aim of the study is to determine whether early cranioplasty can improve on patient's cognitive performance compared to those who undergo the procedure after 3 months.

Detailed Description

Decompressive craniectomy, a neurosurgical procedure where a portion of the skull calvarium is removed, is a life-saving procedure. The complication rate of cranioplasty, a neurosurgical procedure where the acquired skull defect is reconstructed, ranges from 11% to 26% and includes postoperative hemorrhage and infection. (4) The syndrome of the trephined is a recognized long-term complication in which certain groups of patients, experience debilitating neurocognitive deficits in addition to chronic headache, dizziness, fatigability and clinical depression. (2) It is believed that the lack of an overlying bone may cause undue significant atmospheric pressure on the underlying cortex, thereby reducing cerebral perfusion and cerebrospinal fluid flow. There are reports that cognitive improvement can be observed in up to 30% of patients after cranioplasty yet the underlying mechanism for this observation is unclear. (1) Some studies have demonstrated enhanced cerebral perfusion by non-invasive investigations, but there is a lack of large scale systematically performed studies to verify such cerebral hemodynamic effects. (1-3) Clinical equipoise exists regarding the optimum timing of cranioplasty procedures after craniectomies. While the anecdotal practice of delaying cranioplasty for at least 3 months after a craniectomy is common, local and overseas observational studies suggest that performing early cranioplasties (i.e. within 3 months) is equally safe in terms of infection and other operative complications. (4-6)

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Age greater than or equal to 18 years-old,
  2. Craniectomy was performed due to head injury, infarct or spontaneous intracerebral hemorrhage, and benign tumors.
  3. Craniectomy skull defect size of >10cm at its longest diameter
  4. Craniectomy performed at any of the Hospital Authority's Neurosurgical Centers after 1st March 2019
Exclusion Criteria
  1. Age older than 80 years-old,
  2. Patients cannot communicate by obeying simple command,
  3. Patients who are unfit for cranioplasty as decided by the treating neurosurgeon
  4. Posterior fossa craniectomy
  5. Craniectomy performed before 1st March 2019
  6. Craniectomy performed at an institution outside the Hospital Authority
  7. Any pre-existing illness that renders the patient moderately or severely disabled before the brain insult.
  8. Patients that need an additional procedure e.g. cerebrospinal fluid shunting with cranioplasty in the same setting.
  9. History of central nervous system infection
  10. Craniectomy-related complications such as hemorrhage or surgical site infection requiring surgical intervention or deemed to affect patient's long-term cognitive outcome
  11. Claustrophobia or any other medical condition that prohibits the patient from undergo MRI scanning
  12. Patients who cannot understand spoken English or Chinese

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
"Early" cranioplasty"Early" cranioplastySubjects undergoing cranioplasty beyond 3 months after craniectomy.
Primary Outcome Measures
NameTimeMethod
Montreal Cognitive Assessment (MOCA)3-months

Minimum (worse): 0/30; Maximum (best) 30/30. Higher values represent a better outcome.

Rivermead Behavioural Memory Test (RBMT)3-months
Neurobehavioural Cognitive State Examination (NCSE)3-months

Multi-domain assessment involving: orientation, attention, registration, comprehension, repetition, naming, construction, calculation, similarities,judgement. Stratification of each domain into mild, moderate and severe impairment. The higher the number the better the outcome.

Secondary Outcome Measures
NameTimeMethod
Quality of life assessment3-months

Short Form-36 (SF-36)

Caregiver3-months

Caregiver self-assessment questionnaire

MRI cerebral perfusion assessment3-months

Cerebral blood flow

Psychological assessment3-months

Beck depression inventory (BDI)

Motor assessment3-months

Medical Research Council limb power

Caregiver assessment3-months

Caregiver Strain Index

Modified Functional Ambulation Category (MFAC)3-months

7 ordinal scale assessment. The lower the scale, the worse the ambulatory ability of the patient. I: bed bound; 2: wheel-chair bound; 3: dependent walker; 4: Assisted walker; 5: Supervised walker; 6: Indoor walker; 7: Outdoor walker (patient can walk anywhere).

Trial Locations

Locations (1)

Kwong Wah Hospital

🇨🇳

Hong Kong, Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath